Skip to content

Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02044679
Enrollment
82
Registered
2014-01-24
Start date
2013-10-31
Completion date
2014-03-31
Last updated
2016-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

Evaluate urine osmolality as a marker of fluid intake, in healthy subjects displaying a wide range of fluid intake behaviors

Interventions

OTHERWater
OTHERNo intervention

Sponsors

Danone Global Research & Innovation Center
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy female and male subjects aged 20- 30 years old (both ages included). * BMI within the range 20-25 kg/m2 (both inclusive). * Height within the range 1.60-1.75 m (both inclusive) for female subjects and 1.70-1.85 m (both inclusive) for male subjects. * Monophasic contraceptive method (female subjects only) * Smoking less than 10 cigarettes/day * Fluid intake habits falling within one of three designated arms

Exclusion criteria

* Pregnant woman (as determined by a pregnancy test) or woman planning to become pregnant during the study; breast-feeding woman. * Any clinically relevant acute or chronic diseases which could interfere with the subjects' safety during the trial, or expose them to undue risk, or which could interfere with the study objectives. * Having participated in a clinical study for the renal diseases or having received any treatment related to the kidneys, cardiovascular disease or to hypertension in the last 12 months.

Design outcomes

Primary

MeasureTime frame
Osmolalitybaseline

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026